# Clinical Trial to Assess the Efficacy and to Evaluate Safety of HT047 in Patients With Acute Ischemic Stroke

> **NCT02828540** · PHASE2 · COMPLETED · sponsor: **Hocheol Kim** · enrollment: 78 (actual)

## Conditions studied

- Ischemic Stroke

## Interventions

- **DRUG:** HT047 High-dose group
- **DRUG:** HT047 Low-dose group
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02828540
- **Lead sponsor:** Hocheol Kim
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-08-04
- **Primary completion:** 2018-08-03
- **Final completion:** 2018-08-03
- **Target enrollment:** 78 (ACTUAL)
- **Last updated:** 2018-10-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02828540

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02828540, "Clinical Trial to Assess the Efficacy and to Evaluate Safety of HT047 in Patients With Acute Ischemic Stroke". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT02828540. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*